In this study, through systematically analyzing the expression and prognostic value of LOX family in GC, we indicated that the LOX family, especially LOX and LOXL2, might play an important role in GC oncogenesis, and they may become biomarkers for predicting tumor prognosis and potential targets for tumor therapy. The gene discussed is LOXL2; the disease is gastric cancer.